Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
10.68
-0.04 (-0.37%)
Feb 21, 2025, 4:00 PM EST - Market closed
Roivant Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Market Capitalization | 7,621 | 8,494 | 5,597 | 3,419 | 502 | - | |
| Market Cap Growth | -4.61% | 51.75% | 63.72% | 580.90% | - | - | |
| Enterprise Value | 2,575 | 2,824 | 5,021 | 1,886 | -326 | - | |
| Last Close Price | 10.68 | 10.54 | 7.38 | 4.94 | 9.78 | - | |
| PE Ratio | - | 1.95 | - | - | - | - | |
| PS Ratio | 65.27 | 68.06 | 91.34 | 61.84 | 21.10 | - | |
| PB Ratio | 1.48 | 1.32 | 3.48 | 1.66 | 0.24 | - | |
| P/TBV Ratio | 1.66 | 1.46 | 5.53 | 2.06 | 0.28 | - | |
| EV/Sales Ratio | 21.00 | 22.63 | 81.94 | 34.11 | - | - | |
| Debt / Equity Ratio | 0.02 | 0.08 | 0.30 | 0.14 | 0.12 | 0.09 | |
| Asset Turnover | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | 0.04 | |
| Inventory Turnover | - | 27.22 | - | - | - | - | |
| Quick Ratio | 37.39 | 24.81 | 6.29 | 11.21 | 9.39 | 23.81 | |
| Current Ratio | 37.91 | 25.24 | 6.60 | 11.64 | 9.99 | 24.09 | |
| Return on Equity (ROE) | -14.64% | 105.04% | -67.05% | -44.82% | -43.17% | -37.30% | |
| Return on Assets (ROA) | -11.62% | -14.04% | -27.08% | -20.26% | -11.71% | -17.22% | |
| Return on Capital (ROIC) | -11.97% | -14.94% | -30.38% | -22.54% | -12.91% | -19.75% | |
| Earnings Yield | -1.53% | 51.20% | -18.03% | -24.72% | -161.17% | - | |
| FCF Yield | -10.23% | -9.03% | -15.29% | -20.33% | -111.12% | - | |
| Buyback Yield / Dilution | 6.79% | -16.59% | -6.43% | -6.30% | -187.64% | -4.93% | |
| Total Shareholder Return | 6.79% | -16.59% | -6.43% | -6.30% | -187.64% | -4.93% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.